Immune Response News and Research

RSS

Biological similarities found between "chemo brain" and brain fog after COVID-19

Brain fog after COVID-19 is biologically similar to cognitive impairment caused by cancer chemotherapy, something doctors often refer to as "chemo brain."

22 May 2024

4 ways vaccine skeptics mislead you on measles and more

Measles is on the rise in the United States. So far this year, the number of cases is about 17 times what it was, on average, during the same period in each of the four years before, according to the Centers for Disease Control and Prevention.

22 May 2024

Novel therapy reprograms immune cells, shrinks prostate and bladder cancers in animal study

A novel therapy that reprograms immune cells to promote antitumor activity helped shrink hard-to-treat prostate and bladder cancers in mice, according to research from the Johns Hopkins Kimmel Cancer Center and its Bloomberg~Kimmel Institute for Cancer Immunotherapy and Johns Hopkins Drug Discovery.

21 May 2024

Impact of CLK kinase inhibitors 1C8 and GPS167 on cancer cell proliferation and metastasis

A new research paper was published in Oncotarget's Volume 15 on May 16, 2024, entitled, "The anticancer potential of the CLK kinases inhibitors 1C8 and GPS167 revealed by their impact on the epithelial-mesenchymal transition and the antiviral immune response."

20 May 2024

Gut bacteria Ruminococcus gnavus can enhance the effects of cancer immunotherapy

Roughly one in five cancer patients benefits from immunotherapy – a treatment that harnesses the immune system to fight cancer.

17 May 2024

Study reveals positive impact of repeat COVID-19 vaccinations

Health-care workers received the first doses of the COVID-19 vaccine in December 2020.

17 May 2024

Vaccine candidate spurs elusive type of broadly neutralizing HIV antibodies

An HIV vaccine candidate developed at the Duke Human Vaccine Institute triggered low levels of an elusive type of broadly neutralizing HIV antibodies among a small group of people enrolled in a 2019 clinical trial.

17 May 2024

Proteins in the blood could warn people of cancer more than seven years before it is diagnosed

Researchers from the UK investigated associations between 1,463 plasma proteins and 19 cancers, using observational and genetic approaches in participants of the UK Biobank.

17 May 2024

Study identifies key gluten peptide triggering leaky gut in celiac patients

Today is International Celiac Day. Celiac disease is a chronic autoimmune condition that occurs in around one per cent of the world's population.

17 May 2024

RPGRIP1L gene expression levels can be a potential prognostic marker for invasive breast cancer

A protein called retinitis pigmentosa GTPase regulator interacting protein 1-like (RPGRIP1L) performs various functions that are important for development and for health throughout life, and mutations in the RPGRIP1L gene have been linked to different diseases.

15 May 2024

COVID-19 virus can breach blood-retinal barrier, study finds

The blood-retinal barrier is designed to protect our vision from infections by preventing microbial pathogens from reaching the retina where they could trigger an inflammatory response with potential vision loss.

14 May 2024

What is the ‘immune self,’ and how can this concept benefit immunological research?

A perspective review discusses the concept of the 'immune self' and how adaptive immune responses are influenced by self-similarity. The study emphasizes advances and challenges in defining self-similarity and its impact on immunological research.

13 May 2024

Plant virus-derived treatment shows promise against metastatic cancers

An experimental treatment made from a plant virus is effective at protecting against a broad range of metastatic cancers in mice, shows a new study from the University of California San Diego.

13 May 2024

Measles vaccine more likely to be completely ineffective in children born by C-section

A study by the University of Cambridge, UK, and Fudan University, China, has found that a single dose of the measles jab is up to 2.6 times more likely to be completely ineffective in children born by C-section, compared to those born naturally.

13 May 2024

Study spotlights differences based on race and gender in melanoma diagnosis, outcomes

Melanoma, an aggressive form of skin cancer that accounts for 75% of all skin-cancer-related deaths, is often detected later in people with darker skin complexions -; and the consequences can be devastating, a Mayo Clinic study reveals.

10 May 2024

Breakthrough research offers promise for developing new immune therapies for cancer

Scientists from Trinity College Dublin have made an important breakthrough that offers promise for developing new immune therapies for cancer.

9 May 2024

Combination immunotherapy treatment enhances immune response for people with malignant gliomas

Investigators at the UCLA Health Jonsson Comprehensive Cancer Center have pinpointed a combination immunotherapy treatment that enhances the immune response for people with malignant gliomas, an aggressive type of brain tumor that is fast growing and difficult to treat.

9 May 2024

Study examines association between neighborhood disadvantage and DNA methylation in brain tissue

A new research paper was published in Aging (listed by MEDLINE/PubMed as "Aging (Albany NY)" and "Aging-US" by Web of Science) Volume 16, Issue 8, entitled, "The association between neighborhood deprivation and DNA methylation in an autopsy cohort."

9 May 2024

Enhancing the ability of natural killer cells to combat hematologic malignancies

A new study reveals a groundbreaking approach to immunotherapy, demonstrating that blocking the interaction between the CD300A receptor and phosphatidylserine (PS) significantly enhances the ability of human natural killer (NK) cells to lyse hematologic malignancies (HMs).

9 May 2024

Researchers discover potential new treatment for alopecia areata

Researchers at MIT, Brigham and Women's Hospital, and Harvard Medical School have developed a potential new treatment for alopecia areata, an autoimmune disorder that causes hair loss and affects people of all ages, including children.

9 May 2024

Immune Response News and Research

Biological similarities found between "chemo brain" and brain fog after COVID-19

4 ways vaccine skeptics mislead you on measles and more

Novel therapy reprograms immune cells, shrinks prostate and bladder cancers in animal study

Impact of CLK kinase inhibitors 1C8 and GPS167 on cancer cell proliferation and metastasis

Gut bacteria Ruminococcus gnavus can enhance the effects of cancer immunotherapy

Study reveals positive impact of repeat COVID-19 vaccinations

Vaccine candidate spurs elusive type of broadly neutralizing HIV antibodies

Proteins in the blood could warn people of cancer more than seven years before it is diagnosed

Study identifies key gluten peptide triggering leaky gut in celiac patients

RPGRIP1L gene expression levels can be a potential prognostic marker for invasive breast cancer

COVID-19 virus can breach blood-retinal barrier, study finds

What is the ‘immune self,’ and how can this concept benefit immunological research?

Plant virus-derived treatment shows promise against metastatic cancers

Measles vaccine more likely to be completely ineffective in children born by C-section

Study spotlights differences based on race and gender in melanoma diagnosis, outcomes

Breakthrough research offers promise for developing new immune therapies for cancer

Combination immunotherapy treatment enhances immune response for people with malignant gliomas

Study examines association between neighborhood disadvantage and DNA methylation in brain tissue

Enhancing the ability of natural killer cells to combat hematologic malignancies

Researchers discover potential new treatment for alopecia areata

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News